If you need more lookups,
subscriptions start at $34 USD/month.
Cheng Liao Location
Shanghai, CN
Cheng Liao Work
Founder and Chairman @ ReGeneLead Therapies (September 2021 - Present)
Group Vice President @ (January 2018 - Present)
Associate Director, Oncology Biology @ (August 2015 - January 2018)
Associate Director @ (January 2014 - June 2015)
Senior Scientist II and Group Leader @ (January 2013 - January 2014)
Senior Research Scientist and Project leader @ (September 2009 - January 2012)
Research Scientist @ (August 2006 - August 2009)
Associate Research Scientist @ (January 2004 - September 2006)
Postdoc Associate @ (September 2002 - January 2004)
Cheng Liao Education
Rutgers University Center for Management Development
Mini-MBA (Biopharmaceutical Innovation)
2012-2012
Peking University
BS (Biotechnology and Molecular Biology)
Shanghai Institutes of Biochemistry and Cell Biology, Chinese Academy of Sciences
Ph.D. (Human Genetics, Molecular biology and Cell biology)
Rutgers University, mini-MBA
Cheng Liao Skills
Immunology
Autoimmune Diseases
In Vitro
Pharmacology
Cell Biology
Molecular Biology
Biochemistry
Biomarkers
Drug Discovery
In Vivo
Cell Based Assays
FACS
Signal Transduction
Asthma
COPD
Animal Models
qPCR
Drug Development
Cell
Translational Medicine
CRO
Assay Development
ELISA
Immunoassays
Public Speaking
Pharmaceutical Research
Scientists
Management
Leadership
Strategy
Research
Oncology
Cheng Liao Summary
Cheng Liao, based in Shanghai, CN, is currently a Group Vice President at Jiangsu Hengrui Medicine Co., Ltd.. Cheng Liao brings experience from previous roles at ReGeneLead Therapies, Johnson & Johnson, AbbVie and EMD Serono, Inc.. Cheng Liao holds a 2012 - 2012 Mini-MBA in Biopharmaceutical Innovation @ Rutgers University Center for Management Development. With a robust skill set that includes Immunology, Autoimmune Diseases, In Vitro, Pharmacology, Cell Biology and more. Cheng Liao has 6 emails on RocketReach.
Looking for a different Cheng Liao?
Find contact details for 700 million professionals.